190 related articles for article (PubMed ID: 3906417)
1. Changes in insulin binding during hemodialysis in uremic patients.
Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
[TBL] [Abstract][Full Text] [Related]
2. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
Rocić B; Breyer D; Granić M; Milutinović S
Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
[TBL] [Abstract][Full Text] [Related]
3. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
Milutinović S; Breyer D; Janković N; Molnar V; Stefović A; Rocić B
Nephron; 1983; 34(2):99-103. PubMed ID: 6346120
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of methylguanidine on insulin binding to its receptor. Mechanism underlying insulin resistance in uremia.
Lee JY; Iwama N; Watarai T; Yamasaki Y; Kawamori R; Kamada T
Diabetes Res Clin Pract; 1991 Sep; 13(3):173-80. PubMed ID: 1959480
[TBL] [Abstract][Full Text] [Related]
6. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
Ferrannini E; Pilo A; Tuoni M
Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor of erythrocytes and glucose metabolism in uremic children.
Namikawa T; Namikawa T; Fujimoto S; Furuse A; Hattori S; Matsuda I; Nakahara C; Ito H
Horm Metab Res; 1983 Apr; 15(4):161-6. PubMed ID: 6345310
[No Abstract] [Full Text] [Related]
8. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
[No Abstract] [Full Text] [Related]
9. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
[TBL] [Abstract][Full Text] [Related]
10. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
Marttinen A; Pasternack A; Koivula T
Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
[TBL] [Abstract][Full Text] [Related]
11. Effect of dialysis treatment on glucose metabolism in uremic patients.
Kaneda H; Mimura N
Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954
[TBL] [Abstract][Full Text] [Related]
12. Effects of hemodialysis on guanidinopropionic acid metabolism.
Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
[TBL] [Abstract][Full Text] [Related]
13. Insulin binding and glycolytic activity in erythrocytes from dialyzed and nondialyzed uremic patients.
Weisinger JR; Contreras NE; Cajias J; Bellorin-Font E; Amair P; Guitierrez L; Sylva V; Paz-Martínez V
Nephron; 1988; 48(3):190-6. PubMed ID: 3352846
[TBL] [Abstract][Full Text] [Related]
14. [Retention of medium sized molecules in uremic serum].
Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
[No Abstract] [Full Text] [Related]
15. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
[TBL] [Abstract][Full Text] [Related]
16. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
Bonomini V; Stefoni S; Casciani CU; Taccone Gallucci M; Albertazzi A; Cappelli P; Mioli V; Boggi R; Mastrangelo F; Rizzelli S
Contrib Nephrol; 1982; 29():133-42. PubMed ID: 7075212
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
Ibels SL; Reardon MF; Nestel PJ
J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
[TBL] [Abstract][Full Text] [Related]
19. [Insulin resistance in the uremic patient: effects of hemodialysis].
Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte Li-Na countertransport in uremic patients: effect of urea.
Sun YF; Tsai CJ; Hsieh CC; Lau YT
Chin J Physiol; 1996; 39(3):177-81. PubMed ID: 8955564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
